Publication: Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis
Date
Authors
Gürel, Selim
Authors
Marcellin, Patric
Buti, Maria
Krastev, Zahary
Di Bisceglie, Adrian M.
Odin, Joseph A.
Dusheiko, Geoffrey
Heathcote, E. Jenny
E. Jenny, Katyna
Coombs, Derek
Mondou, Elsa
Advisor
Language
Type
Publisher:
Wiley
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Bu çalışma, 29 Ekim-02 Kasım 2010 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 61. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.
Source:
Keywords:
Keywords
Gastroenterology & hepatology
Citation
Marcellin, P. vd. (2010). "Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis". Hepatology, 52(4), Supplement, 555A-556A.